Diboronate-Modified Hyaluronic Acid for Glucose-Responsive Insulin Delivery
Language English Country United States Media print-electronic
Document type Journal Article
- MeSH
- Diabetes Mellitus, Experimental * drug therapy MeSH
- Glucose * metabolism MeSH
- Hypoglycemic Agents * administration & dosage chemistry MeSH
- Insulin * administration & dosage chemistry pharmacology MeSH
- Blood Glucose drug effects MeSH
- Hyaluronic Acid * chemistry MeSH
- Boronic Acids * chemistry MeSH
- Drug Delivery Systems * MeSH
- Mice MeSH
- Drug Carriers * chemistry MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Glucose * MeSH
- Hypoglycemic Agents * MeSH
- Insulin * MeSH
- Blood Glucose MeSH
- Hyaluronic Acid * MeSH
- Boronic Acids * MeSH
- Drug Carriers * MeSH
Diabetes requires precise insulin management to maintain glycemic control and prevent severe complications. Glucose-responsive delivery systems envision an autonomous approach to improve insulin therapy. Here, a glucose-sensitive insulin delivery system comprising hyaluronic acid conjugated with a diboronate glucose binder as a carrier for diol-modified insulin is shown. This approach seeks improved precision in insulin delivery, leveraging bidentate glucose binding to achieve enhanced glucose affinity and specificity. Modification of insulin with a diol motif preserves its native conformation and function. These insulin formulations correct blood glucose in diabetic mice, including glucose-responsive function when subjected to a glucose challenge. However, the absence of secondary interactions, such as electrostatic complexation, ultimately limits the duration of function relative to that of previous platforms. Integrating complementary interactions alongside dynamic-covalent glucose binders therefore enhances the functional duration and therapeutic efficacy in the design of glucose-responsive polymeric carriers, offering design insights into the development of new carriers for glucose-responsive insulin delivery.
References provided by Crossref.org